| Bioactivity | H-Gly-Pro-Gly-NH2 is a tripeptide that inhibits HIV-1 replication. H-Gly-Pro-Gly-NH2 inhibits the activity of HIV-1 IIIB and HIV-2 ROD with EC50 values of 35 µM and 30 µM, respectively. H-Gly Pro Gly NH2 inhibits HIV-1 replication in vitro by interfering with capsid formation. H-Gly Pro Gly NH2 has antiviral activity and can be used for virus research[1][2][3]. |
| Invitro | H-Gly-Pro-Gly-NH2 (5、20 和 100 µM) 在感染 HIV-1 SF-2 的 HUT78 细胞中显示抗病毒活性[1]。H-Gly-Pro-Gly-NH2 (100 µM) 在 ACH-2 细胞中破坏 HIV-1 病毒粒子的衣壳[1]。H-Gly-Pro-Gly-NH2 对临床 HIV-1 的抗病毒活性[2] |
| Name | H-Gly-Pro-Gly-NH2 |
| CAS | 141497-12-3 |
| Sequence | H-Gly-Pro-Gly-NH2 |
| Shortening | GPG-NH2 |
| Formula | C9H16N4O3 |
| Molar Mass | 228.25 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Höglund S, et al. Tripeptide interference with human immunodeficiency virus type 1 morphogenesis. Antimicrob Agents Chemother. 2002 Nov;46(11):3597-605. [2]. Andersson E, et al. No cross-resistance or selection of HIV-1 resistant mutants in vitro to the antiretroviral tripeptide glycyl-prolyl-glycine-amide[J]. Antiviral research, 2004, 61(2): 119-124. [3]. Balzarini J, et al. Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)). Int J Biochem Cell Biol. 2004 Sep;36(9):1848-59. |